Citichem India IPO subscription started on Friday, December 27, and will close on January 1, 2025, as per the schedule. The price band is set at ₹70 per share with a face value of ₹10.
Citichem India IPO Subscription Status
Citichem India IPO Subscribed over 27.28x on its First day till 05.00 PM on 27th December.
- Citichem India IPO subscription QIB investors portion is 0.00x times, while NII subscribed 8.43x times and RII investors subscribed 46.12x times.
- The company has received bids for 4,66,02,000 shares against 17,08,001 shares on offer on the First day.
- Citichem India IPO Subscribed over 27.28x on day 1.
About Citichem India IPO
Citichem India Limited was incorporated in 1992 and started a business of the procurement and supply of organic and inorganic chemicals, bulk drugs, and food chemicals to the pharmaceutical sectors. Furthermore, it exports in direct supply of specialty chemicals, bulk drugs, and intermediate products. It is noticeable that this company also sells food preservatives and chemicals under its brand and makes sure of safety in delivering orders and accurate records of sales. It caters complete range of laboratory chemicals, serving as a full-service provider for research and analytical requirements. Moreover, the company specializes in ordering, sourcing, custom manufacturing, and supplying specialty chemicals, bulk drugs, and APIs. These products serve pharmaceutical, paint, and food clients both in India and abroad.
Citichem India IPO Company Financial Report
The company reported revenue of ₹19.61 crore in 2024 against ₹20.94 crore in 2023. The company reported a profit of ₹1.12 crores in 2024 against a Profit of ₹0.36 crores in 2023.
Citichem India IPO GMP:
Citichem India IPO GMP was ₹30 as of Friday, December 27. That indicates the IPO is trading at ₹100 with ₹30 premium in the grey market against the issue price of ₹70.
